PERCEPTIVE ADVISORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001224962

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 115 positions · Total reported value $5.30B · Top-10 concentration 40.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.5% · 26 new · 28 cut · 12 exited

Active Share (vs S&P 500): 98.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +23.3% · vs SPY +8.4% · Prev Value $4.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, PERCEPTIVE ADVISORS LLC disclosed 115 equity positions with a combined reported value of $5.30B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were PRAX ($588.30M), RYTM ($272.57M), ASND ($230.60M). By sector, the heaviest allocations are Health Care 79.3%, Industrials 1.3%. Versus the prior quarter, allocation shifted toward Health Care (+5.0pp), Industrials (+1.0pp) and away from Other (-6.2pp).

Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 26 new positions, trimmed 28 and fully exited 12, a turnover rate of 55.5% of positions. The portfolio's overlap with the prior quarter was 58% of names.

The largest new positions opened in Q4 2025 were XBI ($134.12M), IVVD ($53.81M), DHR ($45.78M).

Of the 12 positions fully exited versus the prior quarter, the largest were MRUS ($127.39M), INSM ($101.11M), VRNA ($55.93M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • XBI SPDR SERIES TRUST · $134.12M
  • IVVD INVIVYD INC · $53.81M
  • DHR DANAHER CORP DEL · $45.78M
  • CDTX CIDARA THERAPEUTICS INC · $36.48M
  • IRON DISC MEDICINE INC · $35.79M
  • JAZZ JAZZ PHARMACEUTICALS PLC · $28.90M
  • PALI PALISADE BIO INC · $28.32M
  • AXGN AXOGEN INC · $25.66M

Fully Exited (vs previous quarter)

  • MRUS MERUS N V · prev qtr: $127.39M
  • INSM INSMED INC · prev qtr: $101.11M
  • VRNA VERONA PHARMA PLC · prev qtr: $55.93M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $53.93M
  • JANX JANUX THERAPEUTICS INC · prev qtr: $7.15M
  • TEM TEMPUS AI INC · prev qtr: $6.86M
  • HTFL HEARTFLOW INC · prev qtr: $5.05M
  • SCPH SCPHARMACEUTICALS INC · prev qtr: $3.31M

Insider Transactions (Form 4)

Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Opt exercise LeonaBio, Inc. 776,648 $0.00 SEC filing
2026-08-26 Buy Immatics N.V. 863,060 $8.69 SEC filing
2026-07-20 Award Freenome, Inc. 5,500,000 $10.00 SEC filing
2026-06-17 Award Kardigan, Inc. 20,706 — SEC filing
2026-04-17 Award MeiraGTx Holdings plc 555,555 $9.00 SEC filing

All insider transactions →

Fund Profile

Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 107 US equity positions with a combined value of $6.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-71841 (status: Approved), registered 2010-10-04
  • Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 17 private funds, of which 6 hedge funds

Portfolio Structure

  • 107 positions · $6.30B reported value (Q2 2026)
  • Top 10 holdings = 47.5% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.8%
  • Average position size: $58.91M

Sector Tilt

  • Health Care 89.0%
  • Industrials 1.2%
  • Financials 0.1%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 26 new, 28 added, 28 reduced, 12 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.3%
Other 19.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.00M $588.30M 11.11%
11.11%
Add
2 2.55M $272.57M 5.15%
5.15%
Reduce
3 1.08M $230.60M 4.36%
4.36%
Reduce
4 2.33M $175.92M 3.32%
3.32%
Add
5 7.99M $173.28M 3.27%
3.27%
Add
6 1.67M $167.49M 3.16%
3.16%
Add
7 4.28M $163.47M 3.09%
3.09%
Add
8 1.10M $134.12M 2.53%
2.53%
New
9 1.20M $121.92M 2.30%
2.30%
Add
10 1.35M $117.95M 2.23%
2.23%
Add
11 1.45M $114.76M 2.17%
2.17%
Add
12 4.46M $110.62M 2.09%
2.09%
Add
13 10.38M $109.03M 2.06%
2.06%
Add
14 3.07M $100.55M 1.90%
1.90%
Add
15 8.28M $100.08M 1.89%
1.89%
Reduce
16 1.47M $95.59M 1.80%
1.80%
Reduce
17 3.04M $94.69M 1.79%
1.79%
Add
18 979.00K $93.35M 1.76%
1.76%
Add
19 6.37M $90.72M 1.71%
1.71%
Hold
20 3.26M $85.88M 1.62%
1.62%
Add
21 6.49M $84.89M 1.60%
1.60%
Hold
22 10.33M $82.09M 1.55%
1.55%
Reduce
23 1.72M $78.55M 1.48%
1.48%
Reduce
24 2.92M $72.97M 1.38%
1.38%
Reduce
25 3.48M $68.05M 1.28%
1.28%
Add
26 3.56M $67.45M 1.27%
1.27%
Add
27 11.83M $66.74M 1.26%
1.26%
Hold
28 414.24K $66.26M 1.25%
1.25%
Add
29 458.34K $61.81M 1.17%
1.17%
Add
30 21.79M $53.81M 1.02%
1.02%
New
31 5.87M $53.00M 1.00%
1.00%
Add
32 315.54K $51.70M 0.98%
0.98%
Add
33 1.99M $50.71M 0.96%
0.96%
Add
34 87.92K $49.79M 0.94%
0.94%
Add
35 1.18M $48.51M 0.92%
0.92%
Hold
36 331.05K $46.95M 0.89%
0.89%
Reduce
37 200.00K $45.78M 0.86%
0.86%
New
38 1.48M $44.75M 0.84%
0.84%
Add
39 9.68M $41.24M 0.78%
0.78%
Hold
40 2.40M $37.81M 0.71%
0.71%
Hold
41 165.13K $36.48M 0.69%
0.69%
New
42 450.74K $35.79M 0.68%
0.68%
New
43 449.29K $35.06M 0.66%
0.66%
Hold
44 110.53K $34.36M 0.65%
0.65%
Reduce
45 1.78M $31.76M 0.60%
0.60%
Add
46 1.14M $30.65M 0.58%
0.58%
Add
47 170.00K $28.90M 0.55%
0.55%
New
48 12.05M $28.32M 0.54%
0.54%
New
49 825.89K $27.97M 0.53%
0.53%
Add
50 266.29K $27.87M 0.53%
0.53%
Reduce

FAQ

What did PERCEPTIVE ADVISORS LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, PERCEPTIVE ADVISORS LLC reported 115 equity positions worth $5.30B in aggregate; its largest disclosed positions were PRAX ($588.30M), RYTM ($272.57M), ASND ($230.60M).

How large is PERCEPTIVE ADVISORS LLC's portfolio?

PERCEPTIVE ADVISORS LLC reported $5.30B of long equity holdings across 115 positions as of 2025-Q4. Top-10 holdings account for 40.5% of reported value.

What is PERCEPTIVE ADVISORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/perceptive-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →